Michael Makris: When a Researcher Is Listed as First Author Without Knowing
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at University of Sheffield, Editor-in-Chief of Research and Practice in Thrombosis and Haemostasis, shared Eric Topol‘s post on LinkedIn:
“This is incredible.
The first author had nothing to do with this paper, and he was added as the main author without his consent!
I note that the corresponding author lists their position at a prestigious US university.
Vanderbilt University has a moral and scientific obligation to investigate and openly report back to the scientific community about what happened here.
The journal and its publisher should also issue a statement about their policies and what went wrong in this case.”
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on LinkedIn:
“This is a fraudulent paper, AI-generated.
My name was used as an author and I had nothing to do with it, never saw it until today.
The ‘Editors’ Angelo Rossi Mori, David Mensah, and Zarnie Khadjesari and this ‘Journal’ should be reported.”
Other posts featuring Michael Makris and Eric Topol on Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention